 BOSTON, Sept. 02, 2021 GLOBE NEWSWIRE -- Ikena Oncology, Inc. Nasdaq: IKNA, a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, taking place on September 13-15, 2021. 